Both in Blank Checks
Oaktree Acquisition Corp. III Life Sciences vs Drugs Made In America Acquisition
Over the past year OACC returned +2.5% and DMAA returned +5.6%; their daily moves had a correlation of -0.05.
OACC +2.5% DMAA +5.6%Growth of $1, one year, split-adjusted
| Metric | OACC | DMAA |
|---|---|---|
| Price | $10.78 | $10.88 |
| Market cap | $265.0M | $264.1M |
| Today | 0.00% | 0.00% |
| 1 month | +0.4% | +1.2% |
| 6 months | +1.9% | +3.8% |
| Year to date | +1.9% | +4.9% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | -$329.7K |
| Dividend yield | — | — |
| Volatility (60d) | 4.7% | 1.8% |
| Short % of float | 0.0% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).